Back to trial details

Intake questionnaire

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Applying to South Oklahoma Heart Research Group · Oklahoma City, Oklahoma

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Diabetes Mellitus, Type 2?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Oklahoma City for study visits?